| NMB | neuromedin B; neuromuscular blockade; neuromuscular blocking; neuromuscular blocker/blocking [drug, ... |
|---|---|
| PNF | proprioceptive neuromuscular facilitation |
| NMT | neuromuscular tension; neuromuscular transmission; N-methyltransferase; N-myristoyltransferase; no m... |
| FNS | frontier nursing service; functional neuromuscular stimulation |
| FSN | functional stimulation, neuromuscular |
| PNF | Proprioceptive Neuromuscular Facilitation |
|---|---|
| FNS | Functional Neuromuscular Stimulation |
| NM | Neuromuscular |
| NMD | Neuromuscular Diseases |
| NMB | Neuromuscular block |
| proprioceptive | <physiology> Capable of receiving stimuli originating in muscles, tendons, and other internal tissues. Origin: L. Proprius, one's own, + capio, to take (05 Mar 2000) |
|---|---|
| proprioceptive mechanism | <physiology> The mechanism of sense of position and movement, by which muscular movements can be adjusted to a great degree of accuracy and equilibrium maintained. (05 Mar 2000) |
| proprioceptive-oculocephalic reflex | doll's eye sign |
| proprioceptive reflexes | <physiology> Any reflex brought about by stimulation of proprioceptors. See: proprioceptor. (05 Mar 2000) |
| proprioceptive sensibility | <physiology> Capable of receiving stimuli originating in muscles, tendons, and other internal tissues. Origin: L. Proprius, one's own, + capio, to take (05 Mar 2000) |
| neuromuscular | <anatomy> Pertaining to muscles and nerves. (18 Nov 1997) |
| neuromuscular agents | Drugs used for their actions on skeletal muscle. Included are agents that act directly on skeletal muscle, those that alter neuromuscular transmission (neuromuscular blocking agents), and drugs that act centrally as skeletal muscle relaxants (muscle relaxants, central). Drugs used in the treatment of movement disorders are anti-dyskinesia agents. (12 Dec 1998) |
| neuromuscular blockade | The intentional interruption of transmission at the neuromuscular junction by external agents, usually neuromuscular blocking agents. It is distinguished from nerve block in which nerve conduction is interrupted rather than neuromuscular transmission. Neuromuscular blockade is commonly used to produce muscle relaxation as an adjunct to anaesthesia during surgery and other medical procedures. It is also often used as an experimental manipulation in basic research. It is not strictly speaking anaesthesia but is grouped here with anaesthetic techniques. The failure of neuromuscular transmission as a result of pathological processes is not included here. (12 Dec 1998) |
| neuromuscular blocking agent | A group of drugs that prevent motor nerve endings from exciting skeletal muscle. They act either by competing for the neurotransmitter, acetylcholine, (like D-tubocurarine, mivacurium and pancuronium), or by first stimulating the postjunctional muscle membrane and subsequently desensitizing the muscle endplates to the acetylcholine (like succinylcholine or decamethonium); used in surgery to produce paralysis and facilitate manipulation of muscles. (05 Mar 2000) |
| neuromuscular blocking agents | Drugs that interrupt transmission of nerve impulses at the skeletal neuromuscular junction. They can be of two types, competitive, stabilizing blockers (neuromuscular nondepolarising agents) or noncompetitive, depolarising agents (neuromuscular depolarising agents). Both prevent acetylcholine from triggering the muscle contraction and they are used as anaesthesia adjuvants, as relaxants during electroshock, in convulsive states, etc. (12 Dec 1998) |
| neuromuscular cell | A cell of a lower metazoan organism that is both sensitive and contractile. (05 Mar 2000) |
| neuromuscular depolarising agents | Drugs that interrupt transmission at the skeletal neuromuscular junction by causing sustained depolarisation of the motor end plate. These agents are primarily used as adjuvants in surgical anaesthesia to cause skeletal muscle relaxation. (12 Dec 1998) |
| neuromuscular junction | A chemical synapse between a motoneuron and a muscle fibre. Synonym: motor end plate. (18 Nov 1997) |
| neuromuscular nondepolarising agents | Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarisation of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anaesthesia adjuvants. (12 Dec 1998) |
| neuromuscular relaxant | An agent, e.g., curare or succinylcholine, that produces relaxation of striated muscle by interruption of transmission of nervous impulses at the myoneural junction. (05 Mar 2000) |
| proprioceptive neuromuscular facilitation |
a system of therapeutic exercise for the inhibition of spasticity, with emphasis on the training of specific diagonal or spiral body movements against resistance in synergistic patterns; long repetition of involuntary reflex movements is aimed at the eventual development of greater voluntary motor control.
출처: www.mercksource.com/pp/us/cns/cns_hl_dorlands.jspz...
|
|---|---|
| proprioceptive neuromuscular facilitation |
An appproach to therapeutic exercise based on the principles of functional human anatomy and neurophysiology.
출처: sportsmedicine.about.com/cs/exercisephysiology/a/g...
|
| proprioceptive neuromuscular facilitation |
A method of promoting a response of neuromuscular mechanisms through the stimulation of proprioceptors in an attempt to facilitate increased range of motion, increased strength and movement pattern control.
출처: www.methodfitness.com/fitness_glossary_p.shtml
|
| proprioceptive neuromuscular facilitation m. |
see under facilitation.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
| proprioceptive neuromuscular facilitation |
ABBR: PNF. An approach to therapeutic exercise directed at relaxing muscles, increasing joint range of motion, and regaining function by using spiral-diagonal patterns of movement. The principles and te
출처:
|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|